Anadys Pharmaceuticals anadyspharma.com


Public lists: Pharma Startups (4732)

Anadys Pharmaceuticals is a biopharmaceutical company committed to advancing patient care by discovering, developing and commercializing novel and powerful small molecule, anti-infective medicines. These are used for the treatment of hepatitis C virus, or HCV, and bacterial infections. Anadys integrates biology and chemistry into a seamless, feedback-based, iterative process to facilitate rapid and successful drug discovery.

Anadys Pharmaceuticals is a biopharmaceutical company committed to advancing patient care by discovering, developing and commercializing novel and powerful small molecule, anti-infective medicines. These are used for the treatment of hepatitis C viru...Show all

Company (Acquired)

Phone: 858-530-3600

Fax: (858) 527-1540

5871 Oberlin Drive
Suite 200
San Diego, 92121
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Anadys Pharmaceuticals $109.8M Oct 17, 2011
See all 28 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Anadys Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
VenrockVenture CapitalPalo Alto, California, United StatesOther Investors
POSCO Capital (포스코기술투자)Corporate VentureGyeongsangbuk-do, South KoreaOther Investors
CDP CapitalPrivate EquityMontreal, Quebec, CanadaSeries D
International Biomedicine Management PartnersCorporationSwitzerlandSeries D
See all 5 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 28 competitors